Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery
Sponsor: Population Health Research Institute
Summary
The TheRAPy vanguard trial is a multicentre, multiple period randomized, cluster crossover vanguard trial testing the feasibility of a full-scale trial to evaluate whether a centre-based policy of routine use of RAP versus a policy of crystalloid priming reduces RBC transfusion for patients undergoing cardiac surgery on cardiopulmonary bypass. It will also provide information about key parameters of the TheRAPy full-scale trial.
Official title: The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery (TheRAPy): a Multiple Period Vanguard Cluster Crossover Trial
Key Details
Gender
All
Age Range
10 Years - 110 Years
Study Type
INTERVENTIONAL
Enrollment
4500
Start Date
2024-12-04
Completion Date
2026-11
Last Updated
2025-03-04
Healthy Volunteers
Yes
Conditions
Interventions
retrograde autologous priming (RAP)
sites follow an institutional policy of routine use of retrograde autologous priming (RAP) during cardiac surgery
Crystalloid priming
sites implement crystalloid priming use during cardiac surgery
Locations (4)
St. Boniface Hospital
Winnipeg, Manitoba, Canada
Hamilton General Hospital
Hamilton, Ontario, Canada
Montreal Heart Institute
Montreal, Quebec, Canada
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada